Bharat Biotech's nasal vax priced at Rs 800 for private markets

Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at Rs 800 (excluding GST) for private markets and Rs......

'Big Boost': Bharat Biotech's nasal vaccine against Covid cleared for use

The Drugs Controller General of India (DCGI) on Tuesday approved Bharat Biotech's intranasal Covid vaccine for restricted emergency use in those aged above 18 years. "Big Boost to India's Fight......

Covishield, Covaxin get regular market approval

India's drug regulator on Thursday granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, official sources said.......

Padma Bhushan for Indian vaccine makers

Founders of indigenous COVID-19 vaccine developer Bharat Biotech -- Krishna Ella and Suchitra Ella, along with Cyrus Poonawalla, the chairman and MD of another vaccine manufacturer Serum Institute......

'Worst is over for PSU banks'

Those who chatted withmarket expert Pranav Sanghavi on Tuesday expressed concern over the unpredictable state of the stock market and askedfor investment tips. Here isthe transcript: PRANAV......

Chidambaram's Budget speech

Speech of P. Chidambaram Minister of Finance PART A Mr. Speaker, Sir, I rise to present the Budget for the year 2005-06. 2. Last year, while presenting the Budget, I had suggested that the vote in......